World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
43
Citations
7866
World Ranking
5236
National Ranking
447

Overview

Lode Schuerman is affiliated with GlaxoSmithKline in the United Kingdom. Their research primarily focuses on medicine, with significant contributions in infectious diseases, public health, environmental and occupational health, epidemiology, and hepatology.

Their work covers a range of topics including SARS-CoV-2 and COVID-19 research, malaria research and control, mosquito-borne diseases and control, vaccine coverage and hesitancy, hepatitis viruses studies and epidemiology, hepatitis C virus research, and animal virus infections studies.

Recent publications by Lode Schuerman include the following:

  • Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study (2021, The Lancet Infectious Diseases)
  • Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial (2022, The Lancet Infectious Diseases)
  • Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up (2022, Malaria Journal)
  • Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study (2023, EClinicalMedicine)
  • Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial (2023, The Lancet Respiratory Medicine)

Lode Schuerman has collaborated frequently with several co-authors including Matthew Bonaparte, Marguerite Koutsoukos, Roger Masotti, Stephen J. Savarino, and François Roman.

Their publications appear most often in venues such as bioRxiv (Cold Spring Harbor Laboratory), The Lancet Global Health, Vaccine, The Lancet Infectious Diseases, and Malaria Journal.

Best Publications

  • Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

    Roman Prymula;Pascal Peeters;Viktor Chrobok;Pavla Kriz

  • Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials

    Roman Prymula;Claire-Anne Siegrist;Roman Chlibek;Helena Zemlickova

  • Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

    Timo Vesikari;Jacek Wysocki;Bertrand Chevallier;Aino Karvonen

  • Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial

    Arto A Palmu;Jukka Jokinen;Dorota Borys;Heta Nieminen

  • Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.

    Miguel W. Tregnaghi;Xavier Sáez-Llorens;Pio López;Hector Abate

  • Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants.

    Markus Knuf;Heinz-Joesf Schmitt;Joanne Wolter;Lode Schuerman

  • 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix™

    Roman Prymula;Lode Schuerman

  • Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial

    Menno R. van den Bergh;Judith Spijkerman;Kristien M. Swinnen;Nancy A. François

  • Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.

    Isabelle Henckaerts;Nathalie Durant;Dany De Grave;Lode Schuerman

  • Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

    William P Hausdorff;Bernard Hoet;Lode Schuerman

  • Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines

    Jacek Wysocki;Juan C. Tejedor;Dutlef Grunert;Ryszard Konior

  • Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.

    Roman Prymula;Pavla Kriz;Eva Kaliskova;Thierry Pascal

  • Impact of the Conjugation Method on the Immunogenicity of Streptococcus pneumoniae Serotype 19F Polysaccharide in Conjugate Vaccines

    Jan Poolman;Carl Frasch;Anu Nurkka;Helena Käyhty

  • The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.

    Nancy Bermal;Leszek Szenborn;Andrzej Chrobot;Edison Alberto

  • Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

    Markus Knuf;Leszek Szenborn;Masnuel Moro;Christian Petit

  • Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine.

    Irmingard Tichmann-Schumann;Peter Soemantri;Ulrich Behre;Johann Disselhoff

  • Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

    Bertrand Chevallier;Timo Vesikari;Jerzy Brzostek;Markus Knuf

  • Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.

    Arto A Palmu;Jukka Jokinen;Heta Nieminen;Hanna Rinta-Kokko

  • Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.

    Paul A Goepfert;Bo Fu;Anne-Laure Chabanon;Matthew I Bonaparte

  • Immunity to Pertussis 5 Years after Booster Immunization during Adolescence

    Kati Edelman;Qiushui He;Johanna Mäkinen;Anna Sahlberg

  • Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non‐typable Haemophilus influenzae: a randomised double‐blind efficacy study

    Roman Prymula;Pascal Peeters;Viktor Chrobok;Pavla Kriz

Frequent Co-Authors

Jan Poolman
Jan Poolman Janssen (Belgium)
Marcel Tanner
Marcel Tanner Swiss Tropical and Public Health Institute
Fred Zepp
Fred Zepp Johannes Gutenberg University of Mainz
Timo Vesikari
Timo Vesikari Tampere University
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
Clare L. Cutland
Clare L. Cutland University of the Witwatersrand
John Lusingu
John Lusingu University of Copenhagen
James A. Berkley
James A. Berkley University of Oxford
Jussi Mertsola
Jussi Mertsola Turku University Hospital
Amanda J. Leach
Amanda J. Leach Charles Darwin University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various related online degrees and career options. For those interested in healthcare but preferring flexibility, there are numerous online healthcare programs that offer pathways into fields such as clinical lab science or epidemiology, closely tied to microbiology.

If you're considering public health, many students find easy admission online MPH programs a great way to build on microbiology fundamentals while expanding into health policy or disease prevention.

Career paths linked to microbiology include specialized roles such as child life specialists, where understanding diseases and patient care is crucial. For more insight on this field, check out the information on child specialist salary and job requirements.

Additionally, individuals with unique backgrounds might explore options that accommodate diverse circumstances. For example, learning about what is the best degree for a convicted felon can be empowering, showing that returning to education and a scientific career remains possible despite challenges.

Best Scientists Citing Lode Schuerman

Trending Scientists